By Sujay Jadhav – In the complex, high-risk business of pharmaceutical research and development, sponsors face a challenge of picking target products with high therapeutic potential and acceptable safety profile. Then they must efficiently manage costs and timelines.
Read More
Drug pricing, CMS getting negotiating power for drug purchasing, vaccines, clinical trials, artificial intelligence, and Pharmacists becoming care givers. These are the highlights of 2022, what do the experts say we will see in 2023? We rounded up some experts and asked them just that.
With the reporting of 26,000 attendees, HIMSS seems to be getting back on track and moving in the right direction. So what were the reactions? What were the takeaways? Will the exhibitors and attendees return next year? Here is what they told us.
As 2021 comes to an end we like to reach out to our thought leaders to see what they think we can expect next year. So what should we look forward to when it comes to Big Data, Analytics, and AI in health IT?